Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand

BACKGROUND: Many patients develop tumour recurrence within a few years after undergoing surgical resection of gastrointestinal stromal tumours (GIST). Adjuvant imatinib treatment is recommended for patients with high risk of GIST recurrence as it can improve recurrence-free survival and overall surv...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cost Eff Resour Alloc
Main Authors: Bussabawalai, Thanaporn, Thiboonboon, Kittiphong, Teerawattananon, Yot
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6323771/
https://ncbi.nlm.nih.gov/pubmed/30636935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-018-0169-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker